132 related articles for article (PubMed ID: 10022217)
1. Bronchial carcinoid tumours: a study on clinicopathological features and role of octreotide scintigraphy.
Musi M; Carbone RG; Bertocchi C; Cantalupi DP; Michetti G; Pugliese C; Virotta G
Lung Cancer; 1998 Nov; 22(2):97-102. PubMed ID: 10022217
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of ectopic ACTH production from a bronchial carcinoid by imaging with octreotide scintigraphy.
Kristoffersson A; Olsson T; Björnebrink J; Hägg E
Eur J Surg; 1996 Jun; 162(6):515-8. PubMed ID: 8817232
[No Abstract] [Full Text] [Related]
3. Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
Kaltsas GA; Putignano P; Mukherjee JJ; Satta MA; Lowe DG; Britton KE; Monson JP; Grossman AB; Besser GM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):685-9. PubMed ID: 10197087
[TBL] [Abstract][Full Text] [Related]
4. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
Banzo J; Abós MD; Prats E; Delgado M; Razola P; García S; Gomollón F; García F
Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.
Westlin JE; Janson ET; Arnberg H; Ahlström H; Oberg K; Nilsson S
Acta Oncol; 1993; 32(7-8):783-6. PubMed ID: 8305227
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.
Hubalewska-Dydejczyk A; Fröss-Baron K; Mikołajczak R; Maecke HR; Huszno B; Pach D; Sowa-Staszczak A; Janota B; Szybiński P; Kulig J
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1123-33. PubMed ID: 16721571
[TBL] [Abstract][Full Text] [Related]
7. [Bronchial carcinoid tumor and scintigraphy of somatostatin receptors: detection of bone metastasis].
Banzo J; Abós MD; Prats E; García F; Freile E; Razola P; Escalera T
Rev Esp Med Nucl; 2001 Oct; 20(6):431-8. PubMed ID: 11578577
[TBL] [Abstract][Full Text] [Related]
8. [Thoracic SPECT using (111 In-DTPA-D-Phe1)-octreotide in bronchial carcinoid syndrome].
Banzo J; Sebastián A; Prats E; Freile E; García F; Costán J; Razola P; Tomás A; Cegoñino J; Abós MD
Rev Esp Med Nucl; 1998; 17(1):45-8. PubMed ID: 9609844
[TBL] [Abstract][Full Text] [Related]
9. [Cushing's syndrome secondary to bronchial carcinoid tumor: contribution of gammagraphy with 111In-DTPA octreotide in the localization diagnosis].
Peña González E; Lampreave Márquez JL; León Atance P; Moreno Esteban B; Bittini Copano A; Folqué Gómez E
An Med Interna; 1999 Nov; 16(11):577-9. PubMed ID: 10637999
[TBL] [Abstract][Full Text] [Related]
10. Successful localization of an occult ACTH-secreting bronchial carcinoid tumour with 111indium-DTPA labelled octreotide.
Tsagarakis S; Giannakenas C; Vassilakos PJ; Platis O; Belenis I; Kaskarelis J; Rontoyianni D; Thalassinos N
Clin Endocrinol (Oxf); 1995 Dec; 43(6):763-7. PubMed ID: 8736282
[TBL] [Abstract][Full Text] [Related]
11. Imaging of bronchial carcinoid tumors associated to Cushing syndrome with 111In-Octreoscan scintigraphy and immunoscintigraphy with anti-chromogranin monoclonal antibodies. Report of two cases.
Carretta A; Chiesa G; Magnani P; Songini C; Melloni G; Zannini P; Grossi A
J Cardiovasc Surg (Torino); 1997 Apr; 38(2):191-4. PubMed ID: 9201136
[TBL] [Abstract][Full Text] [Related]
12. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Shi W; Johnston CF; Buchanan KD; Ferguson WR; Laird JD; Crothers JG; McIlrath EM
QJM; 1998 Apr; 91(4):295-301. PubMed ID: 9666953
[TBL] [Abstract][Full Text] [Related]
13. [Somatostatin receptor scintigraphy. A new imaging procedure for the specific demonstration of carcinoids of the small intestine].
Dörr U; Räth U; Schürmann G; Höring E; Bach D; Wurm K; Scholz M; Adrian HJ; Bihl H
Rofo; 1993 Jan; 158(1):67-73. PubMed ID: 8425079
[TBL] [Abstract][Full Text] [Related]
14. [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment.
Janson ET; Westlin JE; Eriksson B; Ahlström H; Nilsson S; Oberg K
Eur J Endocrinol; 1994 Dec; 131(6):577-81. PubMed ID: 7804439
[TBL] [Abstract][Full Text] [Related]
15. [Bone scintigraphy and scintigraphy with (111)In-octreotide in the diagnosis of bone metastasis of bronchial carcinoid tumor].
Pérez Angel F; Sánchez Catalicio J; Mohamed Salem L; Castellón Sánchez MI; Navarro Fernández JL; Claver Valderas MA
Rev Esp Med Nucl; 2010; 29(1):38-9. PubMed ID: 19837486
[No Abstract] [Full Text] [Related]
16. A case of bronchial carcinoid: diagnosis and follow-up with 111In-DTPA-octreotide.
Orsolon P; Bagni B; Basadonna P; Geatti O; Talmassons G; Guerra UP
Q J Nucl Med; 1995 Dec; 39(4):311-4. PubMed ID: 8624794
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of atypical bronchial carcinoids with liver metastases, treated with octreotide.
Filosso PL; Ruffini E; Oliaro A; Papalia E; Donati G; Rena O
Eur J Cardiothorac Surg; 2002 May; 21(5):913-7. PubMed ID: 12062286
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67.
Belhocine T; Foidart J; Rigo P; Najjar F; Thiry A; Quatresooz P; Hustinx R
Nucl Med Commun; 2002 Aug; 23(8):727-34. PubMed ID: 12124477
[TBL] [Abstract][Full Text] [Related]
19. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
[TBL] [Abstract][Full Text] [Related]
20. Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours.
Gotthardt M; Béhé MP; Grass J; Bauhofer A; Rinke A; Schipper ML; Kalinowski M; Arnold R; Oyen WJ; Behr TM
Endocr Relat Cancer; 2006 Dec; 13(4):1203-11. PubMed ID: 17158765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]